Search Results

Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.

Microbot Medical Inc. announces that Brigham and Women’s Hospital, a leading academic medical center located in Boston, Massachusetts, will participate as a clinical trial site for the pivotal human clinical trial as part of its Investigational Device Exemption application for its LIBERTY® Endovascular Robotic Surgical System.

Isto Biologics, a global leader in regenerative and autologous therapies, announced the launch of Fibrant Liberty™, a pioneering development within its Fibrant line of allograft solutions.

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders.

ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.

NTT Research, Inc., a division of NTT, announced that the NTT Research Foundation, a 5013 organization, has made a gift to establish the Harvard University Center for Brain Science -NTT Fellowship Program in the new field of Physics of Intelligence.